Search results
New technique improves T cell-based immunotherapies for solid tumors
Medical Xpress· 2 days agoScientists from Scripps Research have enhanced an existing immunotherapy by removing the sugar coating surrounding solid tumors—such as in melanoma, breast, and prostate & ...
What Happens to Your Body When You Eat Green Beans Regularly
Eating Well via Yahoo News· 3 days agoNutrition Facts The nutrient profile of green beans varies depending on the variety, growing...
The future of oncology therapies: Stingray Therapeutics’ immune-boosting breakthrough
Digital Journal· 3 days agoCurrent immune oncology treatments face a critical limitation: they are only effective in about half...
Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
Zacks· 3 days agoExelixis (EXEL) misses on earnings and sales in the first quarter. Its shares are trading down in response to the results.
Q&A: Harnessing the power of the immune system to combat cancer
Digital Journal· 2 days agoImmunotherapy promises to deliver significant results in the battle against different forms of ...
Novartis further entrenches into radiopharma with $1B Mariana buy
FierceBiotech· 1 day agoWith much still to discover in the massive world of radiopharmaceuticals, Novartis will take a deep...
Fans Question Barbara Streisand's Alleged Ozempic Comment on Melissa McCarthy's Photo
Parade via Yahoo News· 3 days ago"Beautiful dress. Uncle Morty has prostate cancer," one quipped. "My regards did you take ozempic?...
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Associated Press via Yahoo Finance· 3 days agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...
Earnings call: Corcept Therapeutics raises 2024 revenue guidance By Investing.com
Investing.com· 1 day agoThe company has also raised its revenue guidance for the full year to between $620 million and $650...
Novartis pays PeptiDream $180M as radiopharma big bang continues
FierceBiotech· 3 days agoJapan’s PeptiDream began working with Novartis in 2010 and, after repeatedly adding to the original deal, formed a collaboration focused on PDCs in 2019. The PDC pact positioned the partners ...